This compound is a steroidal intermediate used in the synthesis of fulvestrant, featuring an ester and an ether functional group with a long alkyl chain protected by a silyl ether.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 875573-60-7
(7R,8R,9S,10R,13S,14S,17S)-7-(9-Bromononyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
research compound
(7a,17b)-7-(9-bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate
Fulvestrant intermediate
(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
Fulvestrant intermediate
(7alpha,17beta)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-triene-3,17-diol
Fulvestrant intermediate
1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane
Fulvestrant intermediate
(7a,17b)-7-(9-((4,4,5,5,5-Pentafluoropentyl)thio)nonyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate
Fulvestrant synthetic intermediate
Ethyl (Z)-3-[(6-amino-3,5-difluoro-2-pyridyl)amino]-2-(2,4,5-trifluorobenzoyl)prop-2-enoate
delafloxacin intermediate
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
[(7R,8R,9S,10R,13S,14S,17S)-7-[9-[tert-butyl(dimethyl)silyl]oxynonyl]-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
UZWBDRNDIWPAKA-QIXFLCTJSA-N
CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@H]34)CCCCCCCCCO[Si](C)(C)C(C)(C)C)C
—